| Ticker Details |
Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$9.68B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.75 | 1.19%
|
| Avg Daily Range (30 D): |
$5.85 | 1.84%
|
| Avg Daily Range (90 D): |
$5.70 | 1.96%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
.21M |
| Avg Daily Volume (90 D): |
.26M |
| Trade Size |
| Avg Trade Size (Sh.): |
47 |
| Avg Trade Size (Sh.) (30 D): |
20 |
| Avg Trade Size (Sh.) (90 D): |
22 |
| Institutional Trades |
| Total Institutional Trades: |
4,484 |
| Avg Institutional Trade: |
$9.32M |
| Avg Institutional Trade (30 D): |
$16.96M |
| Avg Institutional Trade (90 D): |
$15.65M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$11.72M |
| Avg Closing Trade (30 D): |
$19.48M |
| Avg Closing Trade (90 D): |
$19.7M |
| Avg Closing Volume: |
34.58K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$8.23
|
$13.89
|
$-19.69
|
|
Diluted EPS
|
$8.21
|
$13.85
|
$-19.65
|
|
Revenue
|
$2.59B
|
$651M
|
$592.1M
|
|
Gross Profit
|
$1.34B
|
$345.8M
|
$309.4M
|
|
Net Income / Loss
|
$222.4M
|
$371.4M
|
$-527.1M
|
|
Operating Income / Loss
|
$53.1M
|
$72.6M
|
$34.1M
|
|
Cost of Revenue
|
$1.25B
|
$305.2M
|
$282.7M
|
|
Net Cash Flow
|
$164M
|
|
|
|
PE Ratio
|
|
|
|
|
|
|
